BCOP Updates 2025: A Joint Effort: Managing Safe Medical Marijuana Use in Oncology Patients
Medical marijuana (MMJ) has become increasingly utilized by patients diagnosed with cancer. Despite growth in popularity, there is a lack of guidelines, regulation, and acceptance of medical marijuana products. This session will review common indications for cannabis in patients with cancer, pharmacology and pharmacokinetics of medical marijuana (including drug interactions), perceived risks and benefits, data supporting use in oncology patients, and how to collaboratively approach patients interested in using medical marijuana.
BCOP Updates 2025: A Joint Effort: Managing Safe Medical Marijuana Use in Oncology Patients
Authors: Ashley Sabus, PharmD, BCOP, and Erin Barthelmess Goodell, PharmD, BCOP
Learning Objectives
- Review the pharmacology and pharmacokinetics of medical marijuana (MMJ) products
- Discuss evidence-based research surrounding the efficacy of MMJ with a specific focus on its application for supportive care in oncology patients
- Design a plan to minimize adverse effects associated with the use of MMJ
- Apply practical guidelines for cultivating safe use of MMJ in oncology patients across an interdisciplinary team, including shared insights from a hospital-wide cannabinoid education consult team
Get it now!
Knowledge Course for Pharmacists
Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.
HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post-Test with a 75% or higher.
All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.